Anavex Life Sciences
AVXL
#8653
Rank
NZ$0.40 B
Marketcap
NZ$4.32
Share price
-2.16%
Change (1 day)
-76.61%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.79

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.80. a decrease over its 2024 EPS that were of NZ-$0.90.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.933.85%
2024NZ-$0.90-13.33%
2023NZ-$1.04-3.23%
2022NZ-$1.0714.81%
2021NZ-$0.9320%
2020NZ-$0.78-16.67%
2019NZ-$0.9338.46%
2018NZ-$0.6818.18%
2017NZ-$0.57-21.43%
2016NZ-$0.73-35.38%
2015NZ-$1.13-36.27%
2014NZ-$1.77112.5%
2013NZ-$0.83-58.62%
2012NZ-$2.01-0%
2011NZ-$2.01-29.27%
2010NZ-$2.8451.85%
2009NZ-$1.87-0%
2008NZ-$1.87237.5%
2007NZ-$0.55
2006N/A-100%
2005NZ-$0.06925499.97%
2004NZ-$0.01154

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$13.57-1,804.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.78-197.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$13.07 1,541.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$3.00 276.09%๐Ÿ‡บ๐Ÿ‡ธ USA